Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - CASH FROM OPERATIONS
Cash from Operations ALNY - Alnylam Pharmaceuticals, Inc.
-8.31 M
LAST VALUE
87.61%
2 YEAR CAGR
50.46%
5 YEAR CAGR
25.86%
10 YEAR CAGR